Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,020 Results (Page 23 of 51)
- Relevance
  Sort by

CD19 Target Drug Market - Global Forecast 2025-2030

 Report
August 2025
198 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Antifibrotic Drug Market - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

New Molecular Entity Drug Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
119 Pages
Global

From

€4248EUR$4,750USD£3,632GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3129EUR$3,499USD£2,675GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Glioma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4015EUR$4,490USD£3,433GBP

Lymphoma Therapeutics Market - Global Forecast 2026-2032

 Report
August 2026
187 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Non-Hodgkin Lymphoma Treatment Market - Global Forecast 2026-2032

 Report
August 2026
182 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Hodgkin Lymphoma Treatment Market - Global Forecast 2026-2032

 Report
August 2026
194 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

 Report
August 2023
122 Pages
Global

From

€4159EUR$4,650USD£3,555GBP

Curative Therapeutics Market - Global Strategic Business Report

 Report
August 2026
390 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Pediatric Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€4024EUR$4,500USD£3,441GBP

HER2 Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4015EUR$4,490USD£3,433GBP

Addictions Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4015EUR$4,490USD£3,433GBP

Nanomedicine Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4015EUR$4,490USD£3,433GBP

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

 Report
December 2023
134 Pages
Global

From

€2213EUR$2,475USD£1,892GBP

€4427EUR$4,950USD£3,785GBP

Multiple Myeloma Market Report by Drugs Types. Disease Types, End User, Countries and Companies Analysis 2026-2034

 Report
June 2026
200 Pages
Global

From

€2674EUR$2,990USD£2,286GBP

Alcohol Use Disorder - Pipeline Insight, 2026

 Clinical Trials
May 2026
80 Pages
Global

From

€1789EUR$2,000USD£1,529GBP

Hairy Cell Leukemia - Global Strategic Business Report

 Report
August 2026
273 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

T-Xell Lymphoma - Global Strategic Business Report

 Report
August 2026
281 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

1,020 Results (Page 23 of 51)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.